

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.29361261 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.29361261 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.96491897 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.96491897 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62810967 |
| 6 | actin-myosin filament sliding (GO:0033275) | 6.35364654 |
| 7 | muscle filament sliding (GO:0030049) | 6.35364654 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.16217216 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.04013834 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.04013834 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.04013834 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.93557584 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.82034952 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.72043578 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.70163801 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.59814889 |
| 17 | urea metabolic process (GO:0019627) | 5.59142201 |
| 18 | urea cycle (GO:0000050) | 5.59142201 |
| 19 | actin-mediated cell contraction (GO:0070252) | 5.38109826 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.37376296 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.32324853 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31882757 |
| 23 | protein carboxylation (GO:0018214) | 5.31882757 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.27735298 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.19579119 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.18557633 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.16452732 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.13013457 |
| 29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.12698582 |
| 30 | cysteine metabolic process (GO:0006534) | 5.03665364 |
| 31 | bile acid metabolic process (GO:0008206) | 5.00424731 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.96716005 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96610135 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.87297725 |
| 35 | regulation of complement activation (GO:0030449) | 4.86673310 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.81277516 |
| 37 | regulation of skeletal muscle contraction (GO:0014819) | 4.69341747 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.68429628 |
| 39 | lysine catabolic process (GO:0006554) | 4.66887694 |
| 40 | lysine metabolic process (GO:0006553) | 4.66887694 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.66310688 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.65462706 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.65115825 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.64218204 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.62407777 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.62407777 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.62407777 |
| 48 | myofibril assembly (GO:0030239) | 4.58024859 |
| 49 | skeletal muscle contraction (GO:0003009) | 4.55553611 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.54877818 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.54512528 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.54512528 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 4.53994876 |
| 54 | phospholipid efflux (GO:0033700) | 4.45210571 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.38413973 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.38309075 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.38309075 |
| 58 | regulation of relaxation of muscle (GO:1901077) | 4.37066927 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.36392220 |
| 60 | actin filament-based movement (GO:0030048) | 4.36235201 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.34262170 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.27872675 |
| 63 | glycine metabolic process (GO:0006544) | 4.27257286 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.26558661 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.20000382 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.19299398 |
| 67 | amine catabolic process (GO:0009310) | 4.19299398 |
| 68 | cellular glucuronidation (GO:0052695) | 4.18157030 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.17889718 |
| 70 | ethanol oxidation (GO:0006069) | 4.14957971 |
| 71 | creatine metabolic process (GO:0006600) | 4.10571739 |
| 72 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07150634 |
| 73 | modulation by symbiont of host defense response (GO:0052031) | 4.07150634 |
| 74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07150634 |
| 75 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07150634 |
| 76 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07150634 |
| 77 | modulation by symbiont of host immune response (GO:0052553) | 4.07150634 |
| 78 | cholesterol efflux (GO:0033344) | 4.04248334 |
| 79 | sarcomere organization (GO:0045214) | 4.02248173 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.02025676 |
| 81 | glutamate metabolic process (GO:0006536) | 4.01523321 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 4.01095867 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.96651823 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96270864 |
| 85 | negative regulation of cell killing (GO:0031342) | 3.93351832 |
| 86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.93351832 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.93211414 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89635473 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 3.88874899 |
| 90 | arginine metabolic process (GO:0006525) | 3.88011579 |
| 91 | fibrinolysis (GO:0042730) | 3.87267737 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.85755029 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.84218586 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82646911 |
| 95 | detection of external biotic stimulus (GO:0098581) | 3.80215810 |
| 96 | detection of other organism (GO:0098543) | 3.80109629 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77696254 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.77062007 |
| 99 | organic acid catabolic process (GO:0016054) | 3.74723925 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.74723925 |
| 101 | ketone body metabolic process (GO:1902224) | 3.74501339 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.72632405 |
| 103 | aldehyde catabolic process (GO:0046185) | 3.72605723 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.70266721 |
| 105 | drug catabolic process (GO:0042737) | 3.69968410 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 3.69394202 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69208461 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.68946180 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.68946180 |
| 110 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.68697547 |
| 111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66749612 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66749612 |
| 113 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66534680 |
| 114 | cytolysis (GO:0019835) | 3.66512532 |
| 115 | complement activation, classical pathway (GO:0006958) | 3.65505479 |
| 116 | plasma membrane repair (GO:0001778) | 3.65298904 |
| 117 | cofactor catabolic process (GO:0051187) | 3.65188059 |
| 118 | complement activation (GO:0006956) | 3.65155434 |
| 119 | sterol homeostasis (GO:0055092) | 3.64138323 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.63800470 |
| 121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.61986764 |
| 122 | protein activation cascade (GO:0072376) | 3.61033815 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.60417020 |
| 124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60336774 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 3.59645195 |
| 126 | striated muscle contraction (GO:0006941) | 3.59556686 |
| 127 | fatty acid oxidation (GO:0019395) | 3.59183236 |
| 128 | plasma lipoprotein particle organization (GO:0071827) | 3.58862704 |
| 129 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.58722401 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 3.52935115 |
| 131 | skeletal muscle adaptation (GO:0043501) | 3.52569305 |
| 132 | cardiac myofibril assembly (GO:0055003) | 3.42426148 |
| 133 | detection of bacterium (GO:0016045) | 3.39412264 |
| 134 | response to mercury ion (GO:0046689) | 3.39392182 |
| 135 | detection of biotic stimulus (GO:0009595) | 3.32210545 |
| 136 | response to inactivity (GO:0014854) | 3.29095481 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25233827 |
| 138 | cardiac muscle hypertrophy (GO:0003300) | 3.24868714 |
| 139 | response to muscle activity (GO:0014850) | 3.16842735 |
| 140 | actomyosin structure organization (GO:0031032) | 3.13625941 |
| 141 | glucan catabolic process (GO:0009251) | 3.12357694 |
| 142 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.09097345 |
| 143 | cellular polysaccharide catabolic process (GO:0044247) | 3.06840279 |
| 144 | striated muscle hypertrophy (GO:0014897) | 3.05737191 |
| 145 | negative regulation of protein activation cascade (GO:2000258) | 3.02552543 |
| 146 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02100927 |
| 147 | regulation of necroptotic process (GO:0060544) | 3.01526246 |
| 148 | negative regulation of complement activation (GO:0045916) | 2.98338476 |
| 149 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.97705757 |
| 150 | epoxygenase P450 pathway (GO:0019373) | 2.97179927 |
| 151 | macrophage activation (GO:0042116) | 2.97166189 |
| 152 | cellular extravasation (GO:0045123) | 2.96720533 |
| 153 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95472676 |
| 154 | glycogen catabolic process (GO:0005980) | 2.93593805 |
| 155 | growth hormone receptor signaling pathway (GO:0060396) | 2.91174615 |
| 156 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90801939 |
| 157 | germinal center formation (GO:0002467) | 2.90795055 |
| 158 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89980637 |
| 159 | striated muscle adaptation (GO:0014888) | 2.88455594 |
| 160 | cardiac muscle contraction (GO:0060048) | 2.86268787 |
| 161 | regulation of sequestering of triglyceride (GO:0010889) | 2.84675858 |
| 162 | muscle hypertrophy (GO:0014896) | 2.83903780 |
| 163 | muscle contraction (GO:0006936) | 2.81823273 |
| 164 | skeletal muscle tissue regeneration (GO:0043403) | 2.81679384 |
| 165 | microglial cell activation (GO:0001774) | 2.80777759 |
| 166 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.80368176 |
| 167 | polysaccharide catabolic process (GO:0000272) | 2.76714132 |
| 168 | carnitine shuttle (GO:0006853) | 2.75740786 |
| 169 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74572118 |
| 170 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72495868 |
| 171 | striated muscle atrophy (GO:0014891) | 2.71798925 |
| 172 | response to peptidoglycan (GO:0032494) | 2.71472791 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.69511862 |
| 174 | response to host immune response (GO:0052572) | 2.67244425 |
| 175 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67244425 |
| 176 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62847522 |
| 177 | muscle system process (GO:0003012) | 2.62497328 |
| 178 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60602957 |
| 179 | negative regulation of interleukin-12 production (GO:0032695) | 2.60516494 |
| 180 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60199759 |
| 181 | skeletal muscle fiber development (GO:0048741) | 2.59029752 |
| 182 | fatty acid transmembrane transport (GO:1902001) | 2.56458139 |
| 183 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.55695664 |
| 184 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54514932 |
| 185 | neutrophil mediated immunity (GO:0002446) | 2.51823269 |
| 186 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50840062 |
| 187 | response to host (GO:0075136) | 2.50840062 |
| 188 | response to host defenses (GO:0052200) | 2.50840062 |
| 189 | negative regulation of humoral immune response (GO:0002921) | 2.50543151 |
| 190 | cardiac muscle adaptation (GO:0014887) | 2.49661113 |
| 191 | muscle hypertrophy in response to stress (GO:0003299) | 2.49661113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.23967049 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.11012972 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75303918 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43050461 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.34998907 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.36235115 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21881693 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90608101 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04465538 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.84732090 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76874158 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37599553 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35658021 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33301460 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23289847 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02778320 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5986994 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95047716 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86216212 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83346312 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81040080 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76229867 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74149669 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72665683 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64582234 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63947782 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63042330 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57580846 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57104955 |
| 30 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46691059 |
| 31 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.42135459 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40481403 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39322128 |
| 34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36992512 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36856790 |
| 36 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32642809 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30861717 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29606200 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28564314 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22013129 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20175174 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16646913 |
| 43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.15260229 |
| 44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.15260229 |
| 45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.15260229 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11529444 |
| 47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11249922 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04107388 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04054907 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03456599 |
| 51 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01854947 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01430316 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00881700 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99022657 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98137255 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98055993 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95064770 |
| 58 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94306903 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94147710 |
| 60 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93585651 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93103451 |
| 62 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92615798 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91323558 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89426121 |
| 65 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89384862 |
| 66 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89025007 |
| 67 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88583917 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86997368 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86952866 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85759155 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85713103 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 0.85707373 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.85240337 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83388451 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83387740 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82850444 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82420127 |
| 78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82361766 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82297661 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81872002 |
| 81 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81816632 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81591072 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81436120 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.81175788 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79946474 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79423466 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79171048 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78330876 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78245493 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77861908 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77801444 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76837906 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76699457 |
| 94 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75671645 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73429484 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72737109 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72372651 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71991852 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69845151 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67971907 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66560149 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64508231 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64508231 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61411049 |
| 105 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61343849 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60885696 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59936974 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.58987669 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58554709 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58106832 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57602436 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57305714 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56672024 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56508610 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55856104 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55535755 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54901636 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.54788775 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54253478 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54225652 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53904719 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53683062 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53554114 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52440392 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52211816 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.49642993 |
| 127 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49364554 |
| 128 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49026916 |
| 129 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.48836500 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48545305 |
| 131 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.48526514 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.47241410 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45788714 |
| 134 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45264590 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43980752 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43401895 |
| 137 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.43043118 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.42629479 |
| 139 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41588767 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41352070 |
| 141 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40917749 |
| 142 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40917749 |
| 143 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39810524 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39809804 |
| 145 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39223466 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.38705649 |
| 147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.38337457 |
| 148 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.37228079 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36971151 |
| 150 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.36834997 |
| 151 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36487563 |
| 152 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36102710 |
| 153 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.36002211 |
| 154 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35345070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.97988138 |
| 2 | MP0005360_urolithiasis | 7.21802821 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29131346 |
| 4 | MP0005365_abnormal_bile_salt | 6.11211467 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95802489 |
| 6 | MP0003646_muscle_fatigue | 4.89366126 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.16235044 |
| 8 | MP0003252_abnormal_bile_duct | 3.87404334 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.57643629 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.55791143 |
| 11 | MP0000749_muscle_degeneration | 3.42486425 |
| 12 | MP0009840_abnormal_foam_cell | 3.29042638 |
| 13 | MP0000751_myopathy | 3.23784884 |
| 14 | MP0004036_abnormal_muscle_relaxation | 3.14043967 |
| 15 | MP0005083_abnormal_biliary_tract | 3.08216985 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.82928420 |
| 17 | MP0005332_abnormal_amino_acid | 2.69532076 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.66289062 |
| 19 | MP0003195_calcinosis | 2.61873357 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.51321473 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.44508083 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.31378333 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.30244303 |
| 24 | MP0000609_abnormal_liver_physiology | 2.24688967 |
| 25 | MP0004510_myositis | 2.17839279 |
| 26 | MP0000750_abnormal_muscle_regeneration | 2.17224324 |
| 27 | MP0003828_pulmonary_edema | 2.14508498 |
| 28 | * MP0002118_abnormal_lipid_homeostasis | 2.11450136 |
| 29 | MP0000747_muscle_weakness | 2.10077991 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 2.09693784 |
| 31 | MP0004484_altered_response_of | 2.08266350 |
| 32 | MP0005620_abnormal_muscle_contractility | 2.07274725 |
| 33 | MP0003303_peritoneal_inflammation | 2.01980723 |
| 34 | MP0005369_muscle_phenotype | 2.01648294 |
| 35 | MP0002972_abnormal_cardiac_muscle | 1.95122831 |
| 36 | MP0002269_muscular_atrophy | 1.89418110 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.88346045 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.87135992 |
| 39 | MP0004233_abnormal_muscle_weight | 1.86582138 |
| 40 | MP0003868_abnormal_feces_composition | 1.84721597 |
| 41 | MP0000759_abnormal_skeletal_muscle | 1.83092866 |
| 42 | MP0001764_abnormal_homeostasis | 1.62845161 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58428769 |
| 44 | MP0002127_abnormal_cardiovascular_syste | 1.58186000 |
| 45 | MP0009697_abnormal_copulation | 1.57895507 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57662588 |
| 47 | MP0010630_abnormal_cardiac_muscle | 1.56606314 |
| 48 | MP0005451_abnormal_body_composition | 1.54021384 |
| 49 | MP0002419_abnormal_innate_immunity | 1.50445561 |
| 50 | MP0008260_abnormal_autophagy | 1.46326848 |
| 51 | MP0005385_cardiovascular_system_phenoty | 1.37175343 |
| 52 | MP0001544_abnormal_cardiovascular_syste | 1.37175343 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.33771226 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.29593962 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.29291475 |
| 56 | MP0006138_congestive_heart_failure | 1.28142633 |
| 57 | MP0003186_abnormal_redox_activity | 1.26848453 |
| 58 | MP0000598_abnormal_liver_morphology | 1.23925797 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.22261174 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.21099751 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.19918274 |
| 62 | MP0003011_delayed_dark_adaptation | 1.18813753 |
| 63 | MP0005025_abnormal_response_to | 1.15605903 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.15574161 |
| 65 | MP0009764_decreased_sensitivity_to | 1.13904068 |
| 66 | MP0008004_abnormal_stomach_pH | 1.09927058 |
| 67 | MP0009763_increased_sensitivity_to | 1.09838652 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.09713316 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.08972952 |
| 70 | MP0005670_abnormal_white_adipose | 1.08311883 |
| 71 | MP0005647_abnormal_sex_gland | 1.07383532 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.06079243 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.05803304 |
| 74 | MP0000733_abnormal_muscle_development | 1.02127854 |
| 75 | MP0000604_amyloidosis | 1.01623280 |
| 76 | MP0008469_abnormal_protein_level | 0.97910713 |
| 77 | MP0005387_immune_system_phenotype | 0.97031498 |
| 78 | MP0001790_abnormal_immune_system | 0.97031498 |
| 79 | MP0004130_abnormal_muscle_cell | 0.96951192 |
| 80 | MP0001800_abnormal_humoral_immune | 0.95896888 |
| 81 | MP0000685_abnormal_immune_system | 0.95244721 |
| 82 | MP0002254_reproductive_system_inflammat | 0.94884949 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.89924421 |
| 84 | MP0008775_abnormal_heart_ventricle | 0.88262982 |
| 85 | MP0002971_abnormal_brown_adipose | 0.88073199 |
| 86 | * MP0009642_abnormal_blood_homeostasis | 0.87652538 |
| 87 | MP0003045_fibrosis | 0.87206691 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 0.86378714 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.84856540 |
| 90 | MP0002723_abnormal_immune_serum | 0.84743286 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.83822489 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.82410477 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.82034178 |
| 94 | MP0005334_abnormal_fat_pad | 0.79788816 |
| 95 | * MP0002078_abnormal_glucose_homeostasis | 0.79711333 |
| 96 | MP0005000_abnormal_immune_tolerance | 0.79412296 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.78537546 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.78358373 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.77020696 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.76960574 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.76770236 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.76619593 |
| 103 | MP0005408_hypopigmentation | 0.75975241 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.74893850 |
| 105 | MP0001851_eye_inflammation | 0.74796284 |
| 106 | MP0002420_abnormal_adaptive_immunity | 0.72908269 |
| 107 | MP0001819_abnormal_immune_cell | 0.72788285 |
| 108 | MP0005535_abnormal_body_temperature | 0.72089055 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.72075023 |
| 110 | MP0000343_altered_response_to | 0.71899742 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.70273799 |
| 112 | MP0003724_increased_susceptibility_to | 0.69543646 |
| 113 | MP0004947_skin_inflammation | 0.67355859 |
| 114 | MP0000266_abnormal_heart_morphology | 0.66751322 |
| 115 | MP0001661_extended_life_span | 0.65959111 |
| 116 | MP0003436_decreased_susceptibility_to | 0.65284170 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.65164241 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.63914219 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.62644215 |
| 120 | MP0009053_abnormal_anal_canal | 0.62314864 |
| 121 | MP0005266_abnormal_metabolism | 0.61485519 |
| 122 | MP0005448_abnormal_energy_balance | 0.61005235 |
| 123 | MP0003690_abnormal_glial_cell | 0.59772847 |
| 124 | MP0001756_abnormal_urination | 0.58079365 |
| 125 | MP0001853_heart_inflammation | 0.56695502 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.55647482 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.53827372 |
| 128 | MP0002928_abnormal_bile_duct | 0.51209424 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.48734509 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.47391945 |
| 131 | MP0003329_amyloid_beta_deposits | 0.46976079 |
| 132 | MP0006082_CNS_inflammation | 0.46856913 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.46133129 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.45628465 |
| 135 | MP0009115_abnormal_fat_cell | 0.44855650 |
| 136 | MP0008873_increased_physiological_sensi | 0.43924352 |
| 137 | MP0004381_abnormal_hair_follicle | 0.42237299 |
| 138 | MP0003075_altered_response_to | 0.41645073 |
| 139 | MP0005166_decreased_susceptibility_to | 0.41455120 |
| 140 | MP0005395_other_phenotype | 0.41119667 |
| 141 | MP0002970_abnormal_white_adipose | 0.41105843 |
| 142 | MP0009672_abnormal_birth_weight | 0.40741036 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.40703841 |
| 144 | MP0000249_abnormal_blood_vessel | 0.40352764 |
| 145 | MP0003953_abnormal_hormone_level | 0.39958645 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.39484913 |
| 147 | MP0004883_abnormal_blood_vessel | 0.37836450 |
| 148 | MP0008874_decreased_physiological_sensi | 0.37360707 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.35470199 |
| 150 | MP0001243_abnormal_dermal_layer | 0.35388240 |
| 151 | MP0001881_abnormal_mammary_gland | 0.34906911 |
| 152 | MP0005330_cardiomyopathy | 0.34621086 |
| 153 | MP0002060_abnormal_skin_morphology | 0.32893077 |
| 154 | MP0005164_abnormal_response_to | 0.32384341 |
| 155 | MP0003718_maternal_effect | 0.32333866 |
| 156 | MP0009785_altered_susceptibility_to | 0.32149665 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.31794304 |
| 158 | MP0005023_abnormal_wound_healing | 0.31561900 |
| 159 | MP0002168_other_aberrant_phenotype | 0.29866340 |
| 160 | MP0002796_impaired_skin_barrier | 0.28535831 |
| 161 | MP0002132_abnormal_respiratory_system | 0.28287207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.40460551 |
| 2 | Nemaline bodies (HP:0003798) | 8.29937818 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.13431139 |
| 4 | Deep venous thrombosis (HP:0002625) | 7.19407280 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.06420320 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 7.00039463 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.43694827 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 6.30281152 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 6.25032365 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 6.23831010 |
| 11 | Xanthomatosis (HP:0000991) | 6.19408417 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 6.10388288 |
| 13 | Exercise-induced myalgia (HP:0003738) | 6.09653889 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 5.47373219 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.44908569 |
| 16 | Complement deficiency (HP:0004431) | 5.26924274 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.89962387 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.78633433 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.73303019 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.72822259 |
| 21 | Joint hemorrhage (HP:0005261) | 4.69945394 |
| 22 | Hyperammonemia (HP:0001987) | 4.69118095 |
| 23 | Distal arthrogryposis (HP:0005684) | 4.62099983 |
| 24 | Hyperglycinemia (HP:0002154) | 4.47985540 |
| 25 | Epidermoid cyst (HP:0200040) | 4.47740362 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 4.44299656 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42106908 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34924896 |
| 29 | Difficulty running (HP:0009046) | 4.34435475 |
| 30 | Hypoglycemic coma (HP:0001325) | 4.33165731 |
| 31 | Ketosis (HP:0001946) | 4.31778252 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 4.18905256 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 4.11317938 |
| 34 | Hyperglycinuria (HP:0003108) | 4.10219411 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.07540235 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.05360765 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 4.02993233 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02993233 |
| 39 | Fat malabsorption (HP:0002630) | 3.96387120 |
| 40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95940268 |
| 41 | Myopathic facies (HP:0002058) | 3.92980740 |
| 42 | Rhabdomyolysis (HP:0003201) | 3.82580204 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.82436708 |
| 44 | Abnormality of complement system (HP:0005339) | 3.82300828 |
| 45 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.73784632 |
| 46 | Subaortic stenosis (HP:0001682) | 3.73784632 |
| 47 | Abnormality of the calf musculature (HP:0001430) | 3.72097452 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69712750 |
| 49 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.67221012 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.65449632 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64931214 |
| 52 | Hypercholesterolemia (HP:0003124) | 3.59085179 |
| 53 | Neck muscle weakness (HP:0000467) | 3.57025088 |
| 54 | Increased connective tissue (HP:0009025) | 3.56616912 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55940743 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54256257 |
| 57 | Round ear (HP:0100830) | 3.53292128 |
| 58 | Rimmed vacuoles (HP:0003805) | 3.51344939 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 3.46120810 |
| 60 | Ulnar deviation of the wrist (HP:0003049) | 3.42957165 |
| 61 | Orchitis (HP:0100796) | 3.37201483 |
| 62 | Myoglobinuria (HP:0002913) | 3.35596240 |
| 63 | Distal lower limb muscle weakness (HP:0009053) | 3.26622065 |
| 64 | Areflexia of lower limbs (HP:0002522) | 3.23667444 |
| 65 | Hyperbilirubinemia (HP:0002904) | 3.23631492 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 3.21390748 |
| 67 | Ketoacidosis (HP:0001993) | 3.18854616 |
| 68 | Sudden death (HP:0001699) | 3.16062897 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 3.15038125 |
| 70 | Optic neuritis (HP:0100653) | 3.15038125 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 3.11146630 |
| 72 | Myositis (HP:0100614) | 3.05650992 |
| 73 | Myocardial infarction (HP:0001658) | 3.03145903 |
| 74 | Eczematoid dermatitis (HP:0000976) | 2.99867881 |
| 75 | Ventricular tachycardia (HP:0004756) | 2.99563794 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95988584 |
| 77 | Steatorrhea (HP:0002570) | 2.95942311 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.95447277 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.93936482 |
| 80 | Muscle stiffness (HP:0003552) | 2.87841244 |
| 81 | Bundle branch block (HP:0011710) | 2.86270114 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.86027070 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86027070 |
| 84 | Skin nodule (HP:0200036) | 2.86015773 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.81330583 |
| 86 | Metabolic acidosis (HP:0001942) | 2.76638701 |
| 87 | Spontaneous abortion (HP:0005268) | 2.75553769 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.75521071 |
| 89 | Frequent falls (HP:0002359) | 2.67330963 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.63290682 |
| 91 | Lethargy (HP:0001254) | 2.60009853 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.59126501 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.55601948 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.53938699 |
| 95 | EMG: neuropathic changes (HP:0003445) | 2.52416744 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48671751 |
| 97 | Glomerulonephritis (HP:0000099) | 2.47268145 |
| 98 | Vascular calcification (HP:0004934) | 2.46144318 |
| 99 | Facial diplegia (HP:0001349) | 2.45468758 |
| 100 | Acanthocytosis (HP:0001927) | 2.45438574 |
| 101 | Cerebral edema (HP:0002181) | 2.38853191 |
| 102 | Spastic diplegia (HP:0001264) | 2.38613732 |
| 103 | Absent phalangeal crease (HP:0006109) | 2.36483683 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.35771155 |
| 105 | Mitral stenosis (HP:0001718) | 2.35589169 |
| 106 | Dilated cardiomyopathy (HP:0001644) | 2.34995496 |
| 107 | Generalized aminoaciduria (HP:0002909) | 2.32376263 |
| 108 | Esophageal varix (HP:0002040) | 2.32170711 |
| 109 | Recurrent abscess formation (HP:0002722) | 2.31637055 |
| 110 | Cholelithiasis (HP:0001081) | 2.30322853 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 2.28649331 |
| 112 | Stomatitis (HP:0010280) | 2.28343564 |
| 113 | Lipoatrophy (HP:0100578) | 2.27855353 |
| 114 | Gout (HP:0001997) | 2.27743328 |
| 115 | Malignant hyperthermia (HP:0002047) | 2.27261479 |
| 116 | Irritability (HP:0000737) | 2.26982336 |
| 117 | Generalized muscle weakness (HP:0003324) | 2.23444198 |
| 118 | Gingival bleeding (HP:0000225) | 2.23214851 |
| 119 | Cardiovascular calcification (HP:0011915) | 2.19808778 |
| 120 | Pancreatitis (HP:0001733) | 2.18988399 |
| 121 | Neonatal onset (HP:0003623) | 2.18120049 |
| 122 | Cholecystitis (HP:0001082) | 2.17955276 |
| 123 | Abnormal gallbladder physiology (HP:0012438) | 2.17955276 |
| 124 | Renal cortical cysts (HP:0000803) | 2.17285517 |
| 125 | Late onset (HP:0003584) | 2.16733477 |
| 126 | Enlarged kidneys (HP:0000105) | 2.16647844 |
| 127 | Ventricular arrhythmia (HP:0004308) | 2.15741112 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15234236 |
| 129 | Calcaneovalgus deformity (HP:0001848) | 2.15129106 |
| 130 | Menorrhagia (HP:0000132) | 2.14539488 |
| 131 | Peritonitis (HP:0002586) | 2.13245078 |
| 132 | Amyloidosis (HP:0011034) | 2.12509290 |
| 133 | Brushfield spots (HP:0001088) | 2.11362776 |
| 134 | Thrombophlebitis (HP:0004418) | 2.10734053 |
| 135 | Hyperkalemia (HP:0002153) | 2.10287147 |
| 136 | Bulbar palsy (HP:0001283) | 2.09801580 |
| 137 | Keratoconjunctivitis (HP:0001096) | 2.08973784 |
| 138 | Malnutrition (HP:0004395) | 2.08624044 |
| 139 | Recurrent bacterial skin infections (HP:0005406) | 2.08340986 |
| 140 | Vomiting (HP:0002013) | 2.07995775 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 2.06598137 |
| 142 | Arterial thrombosis (HP:0004420) | 2.06060263 |
| 143 | Heart block (HP:0012722) | 2.03433267 |
| 144 | Chest pain (HP:0100749) | 2.03373685 |
| 145 | Abnormality of macrophages (HP:0004311) | 2.02120149 |
| 146 | Hemorrhage of the eye (HP:0011885) | 2.00713288 |
| 147 | Right ventricular cardiomyopathy (HP:0011663) | 2.00589720 |
| 148 | Hyperglycemia (HP:0003074) | 1.98075927 |
| 149 | Opisthotonus (HP:0002179) | 1.97999699 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.97051624 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.97051624 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.96089512 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.95806143 |
| 154 | Abnormality of the endocardium (HP:0004306) | 1.94214091 |
| 155 | Muscular dystrophy (HP:0003560) | 1.93926342 |
| 156 | Gowers sign (HP:0003391) | 1.91420751 |
| 157 | Scapular winging (HP:0003691) | 1.90896437 |
| 158 | Abnormal finger flexion creases (HP:0006143) | 1.90543367 |
| 159 | Hypochromic anemia (HP:0001931) | 1.90353327 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89990630 |
| 161 | Poikilocytosis (HP:0004447) | 1.88817920 |
| 162 | Abnormality of the gallbladder (HP:0005264) | 1.87869531 |
| 163 | Slender build (HP:0001533) | 1.87091357 |
| 164 | Neonatal hypoglycemia (HP:0001998) | 1.87018172 |
| 165 | Nausea (HP:0002018) | 1.84351156 |
| 166 | Toxemia of pregnancy (HP:0100603) | 1.84050298 |
| 167 | Hypertriglyceridemia (HP:0002155) | 1.83973036 |
| 168 | Elevated hepatic transaminases (HP:0002910) | 1.82962064 |
| 169 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.82920016 |
| 170 | Myotonia (HP:0002486) | 1.82317763 |
| 171 | Proximal tubulopathy (HP:0000114) | 1.81541441 |
| 172 | Difficulty climbing stairs (HP:0003551) | 1.81021730 |
| 173 | Abnormal atrioventricular conduction (HP:0005150) | 1.79620722 |
| 174 | Hematochezia (HP:0002573) | 1.79545108 |
| 175 | Pulmonary embolism (HP:0002204) | 1.77976519 |
| 176 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76151635 |
| 177 | Deformed tarsal bones (HP:0008119) | 1.76141880 |
| 178 | Hip contracture (HP:0003273) | 1.75819145 |
| 179 | Distal lower limb amyotrophy (HP:0008944) | 1.75583905 |
| 180 | Nephritis (HP:0000123) | 1.75108845 |
| 181 | Gingivitis (HP:0000230) | 1.74925071 |
| 182 | Rickets (HP:0002748) | 1.74228663 |
| 183 | Ventricular fibrillation (HP:0001663) | 1.67616379 |
| 184 | Hemoptysis (HP:0002105) | 1.65642313 |
| 185 | Anorexia (HP:0002039) | 1.63886536 |
| 186 | Palpitations (HP:0001962) | 1.63457578 |
| 187 | Atrioventricular block (HP:0001678) | 1.61473631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.41152925 |
| 2 | SIK1 | 4.58667021 |
| 3 | ERN1 | 4.24858576 |
| 4 | TTN | 4.09957817 |
| 5 | FGFR4 | 4.05507203 |
| 6 | PKN2 | 3.07914100 |
| 7 | TAOK3 | 2.97554243 |
| 8 | PHKG1 | 2.79628546 |
| 9 | PHKG2 | 2.79628546 |
| 10 | INSRR | 2.75959143 |
| 11 | FLT3 | 2.43860996 |
| 12 | ERBB4 | 2.41130272 |
| 13 | TRIB3 | 2.30510480 |
| 14 | TYK2 | 1.78427670 |
| 15 | MAPK11 | 1.77380274 |
| 16 | MAP2K4 | 1.69274089 |
| 17 | PIK3CG | 1.69242830 |
| 18 | MST1R | 1.66050476 |
| 19 | NEK9 | 1.60848910 |
| 20 | LATS1 | 1.56784140 |
| 21 | DMPK | 1.55105599 |
| 22 | MAP2K3 | 1.50133759 |
| 23 | IRAK4 | 1.49897233 |
| 24 | KDR | 1.46834741 |
| 25 | PTK6 | 1.44899760 |
| 26 | FRK | 1.44208621 |
| 27 | NLK | 1.41687289 |
| 28 | JAK1 | 1.39343767 |
| 29 | KSR2 | 1.36565612 |
| 30 | RIPK4 | 1.31182763 |
| 31 | CAMK1D | 1.30257590 |
| 32 | PRKAA2 | 1.27448555 |
| 33 | JAK2 | 1.21858479 |
| 34 | TBK1 | 1.20265869 |
| 35 | ABL2 | 1.18068436 |
| 36 | MAP3K7 | 1.15009710 |
| 37 | FGFR2 | 1.13483365 |
| 38 | MAP3K10 | 1.12899412 |
| 39 | TGFBR2 | 1.12757306 |
| 40 | HCK | 1.10873939 |
| 41 | TRPM7 | 1.10075798 |
| 42 | MAP3K3 | 1.09651634 |
| 43 | IRAK3 | 1.09337772 |
| 44 | EPHA3 | 1.07918565 |
| 45 | TNK2 | 1.06380224 |
| 46 | RIPK1 | 1.03550110 |
| 47 | EPHB1 | 1.01629866 |
| 48 | FES | 1.01287327 |
| 49 | TIE1 | 1.00484001 |
| 50 | TAOK1 | 0.99162889 |
| 51 | MAP3K14 | 0.95686641 |
| 52 | FGR | 0.95196214 |
| 53 | STK24 | 0.94484631 |
| 54 | IRAK1 | 0.92052195 |
| 55 | DAPK2 | 0.90757107 |
| 56 | CDK6 | 0.90033553 |
| 57 | MAPK4 | 0.88380312 |
| 58 | PINK1 | 0.87949644 |
| 59 | CSK | 0.85018767 |
| 60 | CDK19 | 0.83837525 |
| 61 | MYLK | 0.80640539 |
| 62 | GRK6 | 0.80349949 |
| 63 | ERBB2 | 0.80298088 |
| 64 | MAPK12 | 0.78149297 |
| 65 | FGFR3 | 0.77819470 |
| 66 | YES1 | 0.77758541 |
| 67 | SGK3 | 0.77475130 |
| 68 | MAPK15 | 0.76674896 |
| 69 | STK38L | 0.76367598 |
| 70 | CSF1R | 0.75948593 |
| 71 | MARK2 | 0.75110024 |
| 72 | PTK2B | 0.74539807 |
| 73 | MARK3 | 0.71282941 |
| 74 | PRKAA1 | 0.70952501 |
| 75 | PIK3CA | 0.68937943 |
| 76 | PRKACG | 0.67791982 |
| 77 | MAP3K2 | 0.67786075 |
| 78 | ACVR1B | 0.66631591 |
| 79 | PRKCZ | 0.64818008 |
| 80 | GSK3A | 0.62265412 |
| 81 | DYRK1B | 0.62185521 |
| 82 | OBSCN | 0.61781010 |
| 83 | IKBKE | 0.61257142 |
| 84 | MAP2K6 | 0.59553497 |
| 85 | ZAP70 | 0.58542758 |
| 86 | CAMK2G | 0.57833605 |
| 87 | CDK4 | 0.57516570 |
| 88 | KSR1 | 0.56684125 |
| 89 | MAP4K1 | 0.56103207 |
| 90 | MAP3K11 | 0.56018577 |
| 91 | MET | 0.55961042 |
| 92 | PDK4 | 0.55753347 |
| 93 | PDK3 | 0.55753347 |
| 94 | MAPK7 | 0.55278292 |
| 95 | PRPF4B | 0.55013432 |
| 96 | MAP3K5 | 0.54925716 |
| 97 | SYK | 0.53297929 |
| 98 | MOS | 0.52951005 |
| 99 | IGF1R | 0.52220760 |
| 100 | CAMK1G | 0.52001930 |
| 101 | CDC42BPA | 0.51744983 |
| 102 | PTK2 | 0.50528588 |
| 103 | RAF1 | 0.49820032 |
| 104 | ITK | 0.49784350 |
| 105 | SGK2 | 0.48111776 |
| 106 | DYRK3 | 0.47217526 |
| 107 | FER | 0.47175636 |
| 108 | MUSK | 0.46794454 |
| 109 | KIT | 0.46445148 |
| 110 | STK11 | 0.46057923 |
| 111 | PRKCQ | 0.45591844 |
| 112 | LCK | 0.45584844 |
| 113 | PRKD2 | 0.45458459 |
| 114 | STK38 | 0.43108562 |
| 115 | PDPK1 | 0.42453990 |
| 116 | LYN | 0.42435183 |
| 117 | SGK494 | 0.42233043 |
| 118 | SGK223 | 0.42233043 |
| 119 | PRKD1 | 0.41375950 |
| 120 | RET | 0.40489649 |
| 121 | STK3 | 0.40419731 |
| 122 | WNK1 | 0.39867398 |
| 123 | MAP3K6 | 0.38469467 |
| 124 | TAOK2 | 0.37552521 |
| 125 | BMX | 0.37501421 |
| 126 | BTK | 0.37102509 |
| 127 | MATK | 0.37049050 |
| 128 | RPS6KC1 | 0.36788080 |
| 129 | RPS6KL1 | 0.36788080 |
| 130 | CAMK4 | 0.34981112 |
| 131 | MTOR | 0.34518211 |
| 132 | PDK1 | 0.31974182 |
| 133 | EGFR | 0.30535583 |
| 134 | CSNK1G1 | 0.29544253 |
| 135 | MAP2K1 | 0.28032162 |
| 136 | FGFR1 | 0.27268618 |
| 137 | PRKG2 | 0.26763560 |
| 138 | CHUK | 0.26661414 |
| 139 | JAK3 | 0.24750172 |
| 140 | MAP3K1 | 0.24299529 |
| 141 | ABL1 | 0.24284418 |
| 142 | TXK | 0.23295234 |
| 143 | PKN1 | 0.22677249 |
| 144 | BLK | 0.22424687 |
| 145 | MAP3K13 | 0.21611570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44420816 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49719258 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30154292 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30082444 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97878450 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71760996 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67276913 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67223154 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65767457 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65385223 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48847245 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44721318 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24971199 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11933385 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11178329 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09980209 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06629671 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97220238 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95694704 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.95367405 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89336847 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87561636 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87331646 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85490867 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84398759 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80473294 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77131343 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75646985 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.69700270 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69309188 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68540580 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65530284 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63497103 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61299376 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55344173 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53153926 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49254425 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47807530 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41675912 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.40778435 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40535676 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38671102 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36252321 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35291110 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.30221610 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29244780 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25904274 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25384935 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.24944036 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22952802 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21129012 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.18669604 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17445823 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15370285 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06288539 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 1.06052931 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05571889 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02042114 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00647458 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00110063 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.99870290 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95701916 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94434179 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.91554659 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90591822 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89743136 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88791092 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.88754301 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88738304 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88418778 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86846973 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84733606 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83593859 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80917265 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79699885 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79537810 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79373610 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77846135 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76742303 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76600775 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.76029781 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72970196 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72313387 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70472862 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70404364 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68274951 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67508363 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67061137 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66254856 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65885615 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64895113 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63285907 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62866869 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62279051 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61269759 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60649154 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59626515 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.59432899 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58556527 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.55740885 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52815562 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48822788 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46101872 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45654293 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45633767 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44838587 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44392192 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.44308476 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43279597 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35083521 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31588721 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.30620502 |
| 113 | * Insulin resistance_Homo sapiens_hsa04931 | 0.28418963 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27636858 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20698055 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17255612 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15483769 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14496018 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08355801 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07385850 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01119286 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2245330 |
| 123 | Pertussis_Homo sapiens_hsa05133 | -0.2106496 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2082892 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2015061 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1996743 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1869569 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1859673 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1834648 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | -0.1764776 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1733748 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1629499 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1518606 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | -0.1497021 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1449526 |
| 136 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1345662 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0955355 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0912212 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0801668 |
| 140 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0626180 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0308979 |

